A Lexington company received a multi-million dollar boost and more from Google’s venture capital arm.
SynapDx got a $15.4 million investment from Google Ventures in its efforts to come up with a blood test to diagnose autism, according to a report on Boston Inno. Along with the money, Google’s Andrew Conrad will join SynapDx’s board of directors.
The earliest autism can be diagnosed with a test is 4 ½ years of age, but SynapDX hopes to push that earlier.
Interested in local real estate?Subscribe to Patch's new newsletter to be the first to know about open houses, new listings and more.
Read the entire Boston Inno story by clicking here.
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.
We’ve removed the ability to reply as we work to make improvements. Learn more here